ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.02
0.61%
US Tech 100
21,196.80
0.00%
S&P 500
6,084.19
0.82%
US Dollar vs CAD
1.41349
-0.11%
Bitcoin
101,071.26
-0.12%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Faron Pharmaceuticals Oy (FARN)

  7. Faron Pharmaceuticals Oy (FARN) News

FARN

Faron Pharmaceuticals Oy (FARN)

Faron Pharmaceuticals Oy
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FARN
DateTimeSourceHeadlineSymbolCompany
12/10/20248:31AMAlliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals shares up as presents data on BexmabLSE:FARNFaron Pharmaceuticals Oy
12/10/20241:47AMPR Newswire (US)Faron presents BEXMAB data at ASH Annual MeetingLSE:FARNFaron Pharmaceuticals Oy
12/10/20241:00AMRNS Non-RegulatoryFaron Pharmaceuticals Oy Faron presents BEXMAB data at ASH Annual MeetingLSE:FARNFaron Pharmaceuticals Oy
12/02/20242:00AMRNS Non-RegulatoryFaron Pharmaceuticals Oy Interactions with UK Regulatory AuthoritiesLSE:FARNFaron Pharmaceuticals Oy
11/27/20245:29AMAlliance NewsAlliance NewsFaron announces promising findings from blood cancer drug trialLSE:FARNFaron Pharmaceuticals Oy
11/27/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB TrialLSE:FARNFaron Pharmaceuticals Oy
11/11/20241:00AMRNS Non-RegulatoryFaron Pharmaceuticals Oy Targeting Soluble Clever-1 for Autoimmune DiseasesLSE:FARNFaron Pharmaceuticals Oy
11/05/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Shareholders’ Nomination BoardLSE:FARNFaron Pharmaceuticals Oy
10/22/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Faron’s Capital Markets Day 2024LSE:FARNFaron Pharmaceuticals Oy
10/07/20241:00AMRNS Non-RegulatoryFaron Pharmaceuticals Oy Faron announces Capital Markets DayLSE:FARNFaron Pharmaceuticals Oy
08/30/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Grant of optionsLSE:FARNFaron Pharmaceuticals Oy
08/27/20245:08AMAlliance NewsAlliance NewsFaron Pharma shares surge as US FDA grants fast track designationLSE:FARNFaron Pharmaceuticals Oy
08/27/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy FDA Grants Fast Track Designation for BexmarilimabLSE:FARNFaron Pharmaceuticals Oy
08/27/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Faron 2024 Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
08/20/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
08/13/20247:23AMAlliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals joins US grant for battlefield woundsLSE:FARNFaron Pharmaceuticals Oy
08/13/20241:00AMRNS Non-RegulatoryFaron Pharmaceuticals Oy Traumakine Research Collaboration and DoD GrantLSE:FARNFaron Pharmaceuticals Oy
08/12/20246:01AMAlliance NewsAlliance NewsEXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRxLSE:FARNFaron Pharmaceuticals Oy
08/08/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Appointment of Chief Financial OfficerLSE:FARNFaron Pharmaceuticals Oy
08/07/20244:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Grant of optionsLSE:FARNFaron Pharmaceuticals Oy
08/06/202410:51AMAlliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals names Petri Bono as CMOLSE:FARNFaron Pharmaceuticals Oy
08/06/20242:30AMRNS Regulatory NewsFaron Pharmaceuticals Oy Faron Appoints Dr. Petri Bono as new CMOLSE:FARNFaron Pharmaceuticals Oy
07/11/20241:23PMAlliance NewsAlliance NewsTRADING UPDATES: Titon warns on trading; Videndum revenue in-lineLSE:FARNFaron Pharmaceuticals Oy
07/11/20241:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Faron Announces Positive FDA FeedbackLSE:FARNFaron Pharmaceuticals Oy
06/25/20248:00AMRNS Regulatory NewsFaron Pharmaceuticals Oy Update on settlementLSE:FARNFaron Pharmaceuticals Oy
06/25/20244:30AMRNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in Company - ReplacementLSE:FARNFaron Pharmaceuticals Oy
06/24/20246:45AMRNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
06/24/20246:45AMRNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
06/24/20246:45AMRNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
06/24/20246:45AMRNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
 Showing the most relevant articles for your search:LSE:FARN

Your Recent History

USOTC
DPMLF
Dundee Precious Metals (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved